Somaxon Pharmaceuticals, Inc. 4
4 · Somaxon Pharmaceuticals, Inc. · Filed Feb 20, 2007
Insider Transaction Report
Form 4
Jochelson Philip
Senior VP and Chief Medical
Transactions
- Exercise/Conversion
Stock Option (right to buy)
2007-02-15−900→ 45,916 totalExercise: $2.40Exp: 2015-04-02→ Common Stock (900 underlying) - Sale
Common Stock
2007-02-20$13.01/sh−1,375$17,889→ 0 total - Exercise/Conversion
Stock Option (right to buy)
2007-02-20−1,375→ 44,541 totalExercise: $2.40Exp: 2015-04-02→ Common Stock (1,375 underlying) - Exercise/Conversion
Common Stock
2007-02-20$2.40/sh+1,375$3,300→ 1,375 total - Sale
Common Stock
2007-02-15$13.21/sh−900$11,890→ 0 total - Exercise/Conversion
Common Stock
2007-02-15$2.40/sh+900$2,160→ 900 total
Footnotes (3)
- [F1]This sale was effected by the reporting person pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 9/11/2006, as amended to date.
- [F2]15,201 shares of common stock subject to the option are vested and exercisable as of 2/20/07 and approximately 1,128 vest and become exercisable on the first day of each month until April 1, 2009.
- [F3]Not applicable.